Madeline Mayday

AMKL is a rare leukemia characterized by the improper development of megakaryocytes. In neonates, AMKL is most often caused by a genetic translocation resulting in the RBM15-MKL1 fusion protein. Madeline's work focuses on the effect of this fusion protein on normal and malignant hematopoiesis with the goal of elucidating the mechanism by which it promotes leukemogenesis.

Mentor: Diane Krause